Aurora Cannabis (ACB) Intangibles (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Intangibles of $22.9 million for Q1 2026, down 27.16% year-on-year from $31.5 million in Q1 2025, and down 10.35% on a QoQ basis from $25.6 million in Q4 2025.
Aurora Cannabis (ACB) Intangibles (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Intangibles for 9 consecutive years, with $22.9 million the latest figure, recorded in Q1 2026.
- Quarterly Intangibles fell 27.16% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.9 million (down 27.16% YoY) and the FY2026 annual result came in at $22.8 million, down 29.97% from the prior year.
- Intangibles declined to $22.9 million in Q1 2026 per ACB's latest filing, from $25.6 million in the prior quarter.
- Over the last five years, Intangibles for ACB reached as high as $273.6 million in Q1 2022 and fell as low as $22.9 million in Q1 2026.
- A 5-year average of $53.2 million and a median of $34.0 million in 2025 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles tumbled 83.87% — and 2025, when it advanced 14.12%.
- Year by year, Intangibles stood at $59.3 million in 2022, then retreated by 25.2% to $44.4 million in 2023, then dropped by 29.71% to $31.2 million in 2024, then dropped by 18.02% to $25.6 million in 2025, then decreased by 10.35% to $22.9 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $22.9 million, $25.6 million, and $25.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 22.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.93 Mn |
| Dec 31, 2025 | 25.57 Mn |
| Sep 30, 2025 | 25.42 Mn |
| Jun 30, 2025 | 33.99 Mn |
| Mar 31, 2025 | 31.47 Mn |
| Dec 31, 2024 | 31.20 Mn |
| Sep 30, 2024 | 30.86 Mn |
| Jun 30, 2024 | 29.79 Mn |
| Mar 31, 2024 | 30.32 Mn |
| Dec 31, 2023 | 44.38 Mn |
| Sep 30, 2023 | 44.85 Mn |
| Jun 30, 2023 | 44.55 Mn |
| Mar 31, 2023 | 44.15 Mn |
| Dec 31, 2022 | 59.34 Mn |
| Sep 30, 2022 | 76.48 Mn |
| Jun 30, 2022 | 55.45 Mn |
| Mar 31, 2022 | 273.61 Mn |
| Dec 31, 2021 | 281.60 Mn |
| Sep 30, 2021 | 286.64 Mn |
| Jun 30, 2021 | 298.93 Mn |